Specialized Disclosure Report (sd)
May 22 2020 - 4:34PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________________
FORM SD
Specialized Disclosure Report
___________________
|
|
MASIMO CORPORATION
|
(Exact Name of Registrant as Specified in its Charter)
|
___________________
|
|
|
|
|
|
Delaware
|
|
001-33642
|
|
33-0368882
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification Number)
|
|
|
|
|
|
|
|
52 Discovery
Irvine, California
|
|
92618
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Anand Sampath
(949) 297-7000
(Name and telephone number, including area code, of the person to contact in connection with this report)
___________________
|
|
|
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
|
ý
|
Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2019.
|
|
|
|
Section 1
|
Conflict Minerals Disclosure
|
|
|
Item 1.01
|
Conflict Minerals Disclosure and Report
|
A copy of Masimo’s Conflict Minerals Report for the calendar year ended December 31, 2019 is filed herewith as Exhibit 1.01 and is also available on Masimo’s website at: https://investor.masimo.com/governance/governance-documents/default.aspx
Masimo has filed, as an exhibit to this Form SD, the Conflict Minerals Report required by Item 1.01.
|
|
|
Section 2
|
Exhibits
|
|
|
Item 2.01
|
Exhibits
|
|
|
Exhibit
Number
|
Description of Document
|
1.01
|
|
_____________
Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI and ORI are trademarks or registered trademarks of Masimo Corporation
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
|
|
|
|
|
|
|
|
|
|
|
|
MASIMO CORPORATION
a Delaware corporation
|
|
|
|
|
Date: May 26, 2020
|
|
By:
|
/s/ ANAND SAMPATH
|
|
|
|
Anand Sampath
|
|
|
|
EVP, Operations and Clinical Research
|
|
|
|
|
Masimo (NASDAQ:MASI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Masimo (NASDAQ:MASI)
Historical Stock Chart
From Sep 2023 to Sep 2024